SNANF.US Sona Nanotech Inc

Healthcare Biotechnology USA Stocks
0.1970 USD
Close of Nov 18, 2026
0.1520 0.5240
Market cap
USD 24.2M
P/E
-
P/B
64.97x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2026.

Is SNANF.US undervalued?

Graham number

The Graham number of Sona Nanotech Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sona Nanotech Inc fundamental analysis

No fundamental analysis for Sona Nanotech Inc yet.

Sona Nanotech Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sona Nanotech Inc

Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing. It also engages in the development of targeted hyperthermia therapy, a photo thermal therap…

Full company profile